IL33 and depressive symptom measurement: Additionally, the ST2 receptor, which mediates IL-33 signaling, is downregulated in the prefrontal cortex of MDD patients, implicating the IL-33/ST2 axis as a potential biomarker for inflammatory-driven depression [199].